Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | dopamine receptor D2 | Starlite/ChEMBL | References |
Homo sapiens | dopamine receptor D3 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | hypothetical protein | dopamine receptor D3 | 400 aa | 392 aa | 19.9 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0316 | 1 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0091 | 0.0316 | 1 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.0091 | 0.0316 | 1 |
Echinococcus multilocularis | phosphatidylinositol 3 and 4 kinase | 0.0091 | 0.0316 | 0.0316 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0316 | 1 |
Trypanosoma cruzi | target of rapamycin kinase 3 | 0.0091 | 0.0316 | 0.0978 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0316 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0455 | 0.3232 | 1 |
Trypanosoma brucei | FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative | 0.0057 | 0.0047 | 0.1478 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0316 | 1 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm)-related | 0.0091 | 0.0316 | 1 |
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.0091 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0316 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0057 | 0.0047 | 0.1478 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0316 | 1 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.0091 | 0.0316 | 1 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor1 | 0.0091 | 0.0316 | 0.0978 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0316 | 1 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor2 | 0.0091 | 0.0316 | 0.0978 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0316 | 1 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.0091 | 0.0316 | 1 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0091 | 0.0316 | 0.0978 |
Entamoeba histolytica | phosphatidylinositol3-kinaseTor2, putative | 0.0091 | 0.0316 | 1 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0091 | 0.0316 | 1 |
Trypanosoma brucei | phosphatidylinositol 3-related kinase, putative | 0.0091 | 0.0316 | 1 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0091 | 0.0316 | 1 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0091 | 0.0316 | 1 |
Echinococcus granulosus | FKBP12 rapamycin complex associated protein | 0.0091 | 0.0316 | 0.0316 |
Echinococcus multilocularis | FKBP12 rapamycin complex associated protein | 0.0091 | 0.0316 | 0.0316 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0057 | 0.0047 | 0.1478 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0316 | 1 |
Trypanosoma brucei | phosphatidylinositol 3-kinase, putative | 0.0091 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0316 | 1 |
Echinococcus granulosus | phosphatidylinositol 3 and 4 kinase | 0.0091 | 0.0316 | 0.0316 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0316 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0472 | 0.3371 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0316 | 1 |
Schistosoma mansoni | phosphatidylinositol 3-and 4-kinase | 0.0091 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0316 | 1 |
Toxoplasma gondii | non-specific serine/threonine protein kinase | 0.0057 | 0.0047 | 0.1478 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0091 | 0.0316 | 0.0978 |
Entamoeba histolytica | FKBP-rapamycin associated protein (FRAP), putative | 0.0091 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0316 | 1 |
Echinococcus multilocularis | DNA dependent protein kinase catalytic subunit | 0.1301 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0316 | 1 |
Giardia lamblia | GTOR | 0.0091 | 0.0316 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0057 | 0.0047 | 0.1478 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0316 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | 0 | Displacement of [125I]IABN from human dopamine D4 receptor expressed in HEK293 cells | ChEMBL. | 17672446 |
Ki (binding) | = 1.3 nM | Displacement of [125I]IABN from human dopamine D3 receptor expressed in HEK293 cells | ChEMBL. | 17672446 |
Ki (binding) | = 1.3 nM | Displacement of [125I]IABN from human dopamine D3 receptor expressed in HEK293 cells | ChEMBL. | 17672446 |
Ki (binding) | = 1.3 nM | BindingDB_Patents: Binding Assay. Methods for performing in vitro dopamine receptor binding studies are described in Huang et al. J. Med. Chem. 44:1815-1826 (2001) and Luedtke et al. Synapse 38:438-439 (2000). These papers describe radioactively labeled dopamine receptor selective ligands binding with picomolar affinity and nonselectivity to D2 and D3 dopamine receptors expressed in Sf9 and HEK 293 cells. 125I-IABN binds with 7- to 10-fold lower affinity to human D4.4 dopamine receptors expressed in HEK 293 cells. Dissociation constants (Kd) calculated from kinetic experiments were found to be in agreement with equilibrium Kd values obtained from saturation binding studies. Saturation plots of the binding of 125I-IABN with rat caudate membrane preparations were monophasic and exhibited low nonspecific binding. | ChEMBL. | No reference |
Ki (binding) | = 1.3 nM | BindingDB_Patents: Binding Assay. Methods for performing in vitro dopamine receptor binding studies are described in Huang et al. J. Med. Chem. 44:1815-1826 (2001) and Luedtke et al. Synapse 38:438-439 (2000). These papers describe radioactively labeled dopamine receptor selective ligands binding with picomolar affinity and nonselectivity to D2 and D3 dopamine receptors expressed in Sf9 and HEK 293 cells. 125I-IABN binds with 7- to 10-fold lower affinity to human D4.4 dopamine receptors expressed in HEK 293 cells. Dissociation constants (Kd) calculated from kinetic experiments were found to be in agreement with equilibrium Kd values obtained from saturation binding studies. Saturation plots of the binding of 125I-IABN with rat caudate membrane preparations were monophasic and exhibited low nonspecific binding. | ChEMBL. | No reference |
Ki (binding) | = 68.4 nM | Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells | ChEMBL. | 17672446 |
Ki (binding) | = 68.4 nM | Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells | ChEMBL. | 17672446 |
Ratio Ki (binding) | = 53 | Selectivity for human dopamine D3 receptor over human dopamine D2 receptor | ChEMBL. | 17672446 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.